Health-Tracking Ring Maker Oura Launches $2.2 Billion IPO, Sets $40 to $44 Share Price

Oura, a health-tracking smart ring maker, aims to raise $2.2B in a U.S. IPO, offering 50M shares at $40-$44 each. The company reported $1.21B revenue and 5M paid members as of June 30, with a net loss of $924.3M. Existing shareholders will sell most shares, with a market cap potentially reaching $14.1B.

Original reporting
Published Sep 21, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Health-Tracking Ring Maker Oura Launches $2.2 Billion IPO, Sets $40 to $44 Share Price — source image
Decision brief

The 30-second read

High
01

Why it matters

The IPO provides a new tradable equity for investors seeking exposure to AI‑driven health tech, with significant subscription revenue growth offset by sizable net losses.

02

Market read

The filing signals strong investor demand for health‑tech IPOs and may set a pricing benchmark for similar wearable companies.

03

What to watch

Potential regulatory scrutiny of health data privacy and competition from established smartwatch makers could limit upside.

Relevance 9/10Novelty 9/10Timing: IPO filing disclosed today

Background

Oura, a Finnish wearable health‑tracking ring maker, filed an amended S‑1 to raise up to $2.2 B by selling 50 M shares at $40‑$44 each, valuing the company at roughly $14‑$16 B post‑offering.

Market effects

Adds a high‑growth health‑tech player to the wearable market, potentially boosting related hardware and AI‑driven health service stocks.

Highlights Finland's tech ecosystem and may attract European investor interest in U.S. listings.

Large $2.2 B capital raise underscores continued appetite for AI‑enabled consumer health devices worldwide.

Counterpoint

The IPO valuation may be stretched given Oura's ongoing net losses and reliance on subscription growth.

Key entities

  • Oura

    Health‑tracking smart ring manufacturer seeking a U.S. IPO.

  • Fidelity Management & Research

    One of the major existing shareholders participating in the offering.

Related articles

$COINMedAI 8/10

Coinbase Opens IPO Access — Oura Is First, But There's a Catch

Coinbase launched a new service allowing eligible U.S. retail customers to request allocations in IPOs, starting with Oura's $2.2B IPO. Oura plans to sell 13.5M shares at $40-$44 each, with a fully diluted valuation of about $15.62B. Coinbase's IPO access prioritizes long-term investors, discouraging early selling.

$OURAHighAI 9/10

Smart ring maker Oura targets $2.2 billion in US listing

Oura Inc, a smart ring maker, aims to raise $2.2B in a US IPO, offering 50M shares at $40-$44 each. The company could be valued at $14.1B-$15B. Oura reported a $924.3M net loss on $1.21B revenue for the nine months ended June 30. The IPO is expected to price on September 29, with shares trading on Nasdaq under ticker OURA.

$COINHigh

Coinbase IPO News: US Retail Access Opens, With Oura Up First

Coinbase launched a feature allowing eligible US retail customers to request IPO shares, starting with Oura. Oura plans to offer 13.5M shares priced between $40 and $44, listing on Nasdaq as OURA. Coinbase's stock (COIN) rose 3.5% to $201.05 on the news, with a market cap of $53.04B. Oura's IPO is expected to price this week.

$OURAHighAI 9/10

Oura smart ring IPO roadshow launches, targets $2.2 billion

Oura Health launched its IPO, aiming to raise $2.2B by selling 50M shares at $40-$44 each, targeting a $15.62B valuation. Trading under 'OURA' on Nasdaq, it sold 3.6M rings in the past year with $1.21B revenue. Eli Lilly and Dragoneer may invest $100M and $300M respectively. The company faces a lawsuit over sleep tracking accuracy claims.

HighAI 8/10

Oura’s IPO seeks $2.2bn, and 73% of it goes to existing shareholders

Oura, a Finnish smart ring maker, launched its IPO, offering 50 million shares at $40-$44 each, potentially raising $2.2bn. The company will receive $594m, while existing shareholders will get $1.61bn. Oura plans to list on Nasdaq under the ticker OURA. The company's membership revenue grew 121% to $240.5m in nine months, with a gross margin of 89%. Oura guides towards 5.7 million paid members by the end of fiscal 2026.